Start-up of new clinical trials put on hold at Sachsska barnsjukhuset

Start-up of new clinical trials put on hold at Sachsska barnsjukhuset

Nyheter
News
Calmark Sweden AB (publ) announces today that new clinical trials in cooperation with the research unit at the children's hospital Sachsska barnsjukhuset, part of Södersjukhuset AB, Stockholm, will not be able to start in the coming months. The reason is that resources must be re-prioritized due to the situation with COVID-19. Further notice is expected.

“The current situation is unfortunate, but we fully understand the priorities set by the healthcare system,” says Anna Söderlund, CEO. “Our current focus is on the production and marketing of our two CE-marked products, Neo-Bilirubin and COVID19-LDH.”

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.